Crystals are an essential component of nuclear medicine imaging systems, and manufacturers use several different types of crystals to capture and power the cameras. With the number of options in the market, it’s easy to become overwhelmed by all the choices. This post reviews the primary crystals used in nuclear
Purchasing a nuclear gamma camera is a significant investment and one that should be carefully weighed. In addition to evaluating new imaging systems, most practices also consider a used or refurbished system. Which choice is best and what is right for your practice? As with any long-term purchase, there are
After years of discussion, negotiation, and delays, sweeping changes to the Physician Self-Referral Law, or as it’s commonly known – Stark Law, took effect earlier this year. While the passage of the original bill was met with resistance, these updates were intended to clarify and modernize components of the law
Last month, the Centers for Medicare and Medicaid Services (CMS) announced that the Medicare Appropriate Use Criteria Program deadline had been extended yet again. Originally slated to take effect on January 1, 2021, the new deadline extends the start date by a full year. The rules and reimbursement guidance was
The entire medical system of the United States has been focused on a single threat over the past eight weeks. While the dangers from COVID-19 remain present, many states are beginning to open back up, and as capacity increases, medical facilities are easing back into seeing patients. Along with the
Digirad’s blog provides a variety of resources that keep you up to date on the ever-changing healthcare industry, including the advancements and issues that directly impact the operation of your practice. As we kick off a new year, here’s a look back at Digirad’s Top 5 Blog Posts from 2018:
PET/CT is a vital diagnostic imaging tool and is especially effective in revealing conditions such as cancer and brain disorders. When it comes to Medicare coverage, there are a number of misconceptions about PET/CT reimbursements. In the majority of cases, PET/CT imaging is covered when clinically necessary, either as an
The large majority of the nuclear imaging community would be quick to point out that PET/CT imaging with either 18Fluorodeoxyglucose (18FDG), or Sodium 18Fluoride (NaF18), is not effective in prostate cancer diagnosis. In fact, it’s not even approved for initial prostate treatment strategy. With oncology imaging, most other cancers are
Subscribe to the Digirad Newsletter for the latest updates.
©2021 Digirad Corporation. All rights reserved.